Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment

To investigate the natural history of renal cell carcinoma (RCC) with delayed treatment and to immunohistochemically analyze the correlation between some biomarkers and the growth rate of RCC. Methods: We reviewed our institutional databases to identify renal tumors which were confirmed to be RCC by...

Full description

Bibliographic Details
Main Authors: Lei Zhang, Lin Yao, Xuesong Li, Michael A.S. Jewett, Zhisong He, Liqun Zhou
Format: Article
Language:English
Published: Elsevier 2016-06-01
Series:Journal of the Formosan Medical Association
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664615001734
id doaj-9d77cce0b16f4662b6803744e9153f5a
record_format Article
spelling doaj-9d77cce0b16f4662b6803744e9153f5a2020-11-24T22:28:10ZengElsevierJournal of the Formosan Medical Association0929-66462016-06-01115646346910.1016/j.jfma.2015.05.003Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatmentLei Zhang0Lin Yao1Xuesong Li2Michael A.S. Jewett3Zhisong He4Liqun Zhou5Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, ChinaDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, ChinaDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, ChinaDivision of Urology and Department of Surgical Oncology, Princess Margaret Hospital, University of Toronto, Toronto, CanadaDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, ChinaDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, ChinaTo investigate the natural history of renal cell carcinoma (RCC) with delayed treatment and to immunohistochemically analyze the correlation between some biomarkers and the growth rate of RCC. Methods: We reviewed our institutional databases to identify renal tumors which were confirmed to be RCC by delayed surgical treatment after at least 12 months of active surveillance (AS). Growth rate was defined as the average growth rate of the maximal diameter on computed tomography or magnetic resonance imaging. The clinicopathological characteristics and immunohistochemical biomarkers (Ki-67, p53, bcl-2, and vascular endothelial growth factor) were analyzed the correlation with the growth rate of RCC. Results: We identified 45 RCCs from 45 patients. The mean patient age was 54 years (range, 26–78 years). The mean tumor size increased from 2.39 cm (range, 0.10–6.70 cm) at presentation to 4.54 cm (range, 1.40–11.80 cm) after a mean time of 45.4 months (range, 12–155 months) of AS. The mean growth rate was 0.79 cm/y (range, 0.10–4.74 cm), and 36 (80.0%) tumors presented a growth rate ≤ 1.00 cm/y. Clear cell RCC had a trend of growing faster than other histological subtypes. Pathological grade was significantly correlated with the growth rate of RCC (p = 0.043). High positive ratio of Ki-67 (r = 0.351, p = 0.018) and being p53 positive (p = 0.019) were significantly correlated to the fast growth rate of RCC. Conclusion: In general, RCCs under AS are slow growing with a wide variation of growth rate, with a portion of RCCs presenting rapid growth kinetics. RCC with rapid growth during AS is characterized by a high histological grade, high positive ratio of Ki-67, and being p53 positive.http://www.sciencedirect.com/science/article/pii/S0929664615001734active surveillancedelayed interventiongrowth rateimmunohistochemical analysisrenal cell carcinoma
collection DOAJ
language English
format Article
sources DOAJ
author Lei Zhang
Lin Yao
Xuesong Li
Michael A.S. Jewett
Zhisong He
Liqun Zhou
spellingShingle Lei Zhang
Lin Yao
Xuesong Li
Michael A.S. Jewett
Zhisong He
Liqun Zhou
Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment
Journal of the Formosan Medical Association
active surveillance
delayed intervention
growth rate
immunohistochemical analysis
renal cell carcinoma
author_facet Lei Zhang
Lin Yao
Xuesong Li
Michael A.S. Jewett
Zhisong He
Liqun Zhou
author_sort Lei Zhang
title Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment
title_short Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment
title_full Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment
title_fullStr Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment
title_full_unstemmed Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment
title_sort natural history of renal cell carcinoma: an immunohistochemical analysis of growth rate in patients with delayed treatment
publisher Elsevier
series Journal of the Formosan Medical Association
issn 0929-6646
publishDate 2016-06-01
description To investigate the natural history of renal cell carcinoma (RCC) with delayed treatment and to immunohistochemically analyze the correlation between some biomarkers and the growth rate of RCC. Methods: We reviewed our institutional databases to identify renal tumors which were confirmed to be RCC by delayed surgical treatment after at least 12 months of active surveillance (AS). Growth rate was defined as the average growth rate of the maximal diameter on computed tomography or magnetic resonance imaging. The clinicopathological characteristics and immunohistochemical biomarkers (Ki-67, p53, bcl-2, and vascular endothelial growth factor) were analyzed the correlation with the growth rate of RCC. Results: We identified 45 RCCs from 45 patients. The mean patient age was 54 years (range, 26–78 years). The mean tumor size increased from 2.39 cm (range, 0.10–6.70 cm) at presentation to 4.54 cm (range, 1.40–11.80 cm) after a mean time of 45.4 months (range, 12–155 months) of AS. The mean growth rate was 0.79 cm/y (range, 0.10–4.74 cm), and 36 (80.0%) tumors presented a growth rate ≤ 1.00 cm/y. Clear cell RCC had a trend of growing faster than other histological subtypes. Pathological grade was significantly correlated with the growth rate of RCC (p = 0.043). High positive ratio of Ki-67 (r = 0.351, p = 0.018) and being p53 positive (p = 0.019) were significantly correlated to the fast growth rate of RCC. Conclusion: In general, RCCs under AS are slow growing with a wide variation of growth rate, with a portion of RCCs presenting rapid growth kinetics. RCC with rapid growth during AS is characterized by a high histological grade, high positive ratio of Ki-67, and being p53 positive.
topic active surveillance
delayed intervention
growth rate
immunohistochemical analysis
renal cell carcinoma
url http://www.sciencedirect.com/science/article/pii/S0929664615001734
work_keys_str_mv AT leizhang naturalhistoryofrenalcellcarcinomaanimmunohistochemicalanalysisofgrowthrateinpatientswithdelayedtreatment
AT linyao naturalhistoryofrenalcellcarcinomaanimmunohistochemicalanalysisofgrowthrateinpatientswithdelayedtreatment
AT xuesongli naturalhistoryofrenalcellcarcinomaanimmunohistochemicalanalysisofgrowthrateinpatientswithdelayedtreatment
AT michaelasjewett naturalhistoryofrenalcellcarcinomaanimmunohistochemicalanalysisofgrowthrateinpatientswithdelayedtreatment
AT zhisonghe naturalhistoryofrenalcellcarcinomaanimmunohistochemicalanalysisofgrowthrateinpatientswithdelayedtreatment
AT liqunzhou naturalhistoryofrenalcellcarcinomaanimmunohistochemicalanalysisofgrowthrateinpatientswithdelayedtreatment
_version_ 1725747565626916864